Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Israel-based drugmaker Teva Pharmaceuticals has agreed to end a patent lawsuit over Eli Lilly's migraine drug Emgality following a U.S. Patent Office decision that invalidated the Teva patents at ...

A Boston federal judge on Monday rejected Eli Lilly & Co's request to invalidate three Teva Pharmaceuticals International GmbH patents in a long-running legal battle over the companies' competing ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed ...

A Massachusetts federal judge has sided with Eli Lilly in a patent spat, overturning a $176.5 million jury verdict from November of last year.. The verdict had been awarded to Teva in a patent ...

TEVA Teva Pharmaceutical Industries Ltd $16.76 1.21 % A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co LLY .

With short film, Eli Lilly is Seeking to transform itself as a drugmaker Jack O'Brien May 19, 2025 ; The Escalator: Eli Lilly, Galapagos, UnitedHealth Group and more Heerea Rikhraj May 16, 2025 ; The ...

A federal jury in Boston awarded Teva Pharmaceuticals International GmbH $176.5 million in damages in a patient infringement suit against Eli Lilly and Co. for its migraine medication, Emgality.

Eli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court ...

Eli Lilly ordered to pay $176.5 mln to Teva in U.S. migraine drug patent trial. US judge overturns Eli Lilly's $176.5 million loss in Teva patent case.